Clinical trials
Phase 1/2 Prostatic Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 6 |
| Recruiting | 5 |
| Terminated | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sunnybrook Health Sciences Centre | 6 |
| University Health Network, Toronto | 6 |
| AHS Cancer Control Alberta | 2 |
| Alberta Health services | 2 |
| AstraZeneca | 2 |
| ESSA Pharmaceuticals | 2 |
| GlaxoSmithKline | 2 |
| University of Guelph-Humber | 2 |
| Astex Pharmaceuticals, Inc. | 1 |
| Fraser Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 34 |
| Urinary Bladder Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Uterine Cervical Neoplasms | 2 |
| Adenoviridae Infections | 1 |
| Biliary Tract Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
| Genital Diseases, Male | 1 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.